These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 538990)
21. [Fluoride in osteoporosis: not yet validated]. Pols HA Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1902-3. PubMed ID: 9856174 [TBL] [Abstract][Full Text] [Related]
22. Fluoride in the prevention and treatment of osteoporosis. Inkovaara JA Adv Nutr Res; 1994; 9():231-43. PubMed ID: 7747668 [No Abstract] [Full Text] [Related]
23. [Increase in bone mineral density and its effect on fracture risk]. Sone T Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775 [TBL] [Abstract][Full Text] [Related]
24. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Feldstein A; Elmer PJ; Orwoll E; Herson M; Hillier T Arch Intern Med; 2003 Oct; 163(18):2165-72. PubMed ID: 14557214 [TBL] [Abstract][Full Text] [Related]
25. Fluoride treatment of osteoporosis: a new look at an old drug. Bikle DD Ann Intern Med; 1983 Jun; 98(6):1013-5. PubMed ID: 6859684 [No Abstract] [Full Text] [Related]
26. Treatment of vertebral osteoporosis with fluoride and calcium. Meunier PJ Prog Clin Biol Res; 1990; 332():221-30. PubMed ID: 2184440 [No Abstract] [Full Text] [Related]
27. Osteoporosis management. Rozenberg S; Vandromme J; Ayata NB; Filippidis M; Kroll M Int J Fertil Womens Med; 1999; 44(5):241-9. PubMed ID: 10569453 [TBL] [Abstract][Full Text] [Related]
28. [Up-to-date treatments for osteoporosis]. Bors K Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157 [TBL] [Abstract][Full Text] [Related]
30. Selection of individuals for prevention of fractures due to bone fragility. Seeman E Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun; 14(2):233-49. PubMed ID: 11035904 [TBL] [Abstract][Full Text] [Related]
31. [Conclusive evaluation of osteoporosis therapy with fluorides]. Hesch RD; Rittinghaus EF Internist (Berl); 1991 Dec; 32(12):708-20. PubMed ID: 1783513 [No Abstract] [Full Text] [Related]
32. Etidronic acid and steroid therapy: new indication. No proven impact on fractures. Prescrire Int; 1999 Aug; 8(42):111-2. PubMed ID: 11503828 [TBL] [Abstract][Full Text] [Related]
33. The reversibility of disuse osteoporosis. Fluoride treatment and bone strength. Rosenquist JB; Spengler DM; Mattsson S Clin Orthop Relat Res; 1977; (126):305-8. PubMed ID: 598136 [TBL] [Abstract][Full Text] [Related]
34. [Osteoporosis of the elderly: therapeutic possibilities]. Minne HW Wien Med Wochenschr; 1990 Oct; 140(18-19):479-82. PubMed ID: 2174592 [TBL] [Abstract][Full Text] [Related]
35. Half the burden of fragility fractures in the community occur in women without osteoporosis. When is fracture prevention cost-effective? Sanders KM; Nicholson GC; Watts JJ; Pasco JA; Henry MJ; Kotowicz MA; Seeman E Bone; 2006 May; 38(5):694-700. PubMed ID: 16507356 [TBL] [Abstract][Full Text] [Related]
38. Fluoride for the treatment of osteoporosis. Lesser GT Ann Intern Med; 1999 Feb; 130(3):240-1. PubMed ID: 10049208 [No Abstract] [Full Text] [Related]
39. [Bone complications during the treatment of osteoporosis with fluor]. Marcelli C; Pansard E; Thomas E; Hérisson C; Simon L Rev Med Interne; 1989; 10(2):118-26. PubMed ID: 2740660 [TBL] [Abstract][Full Text] [Related]
40. Effect of fluoride on postmenopausal osteoporosis. N Engl J Med; 1990 Aug; 323(6):416-7. PubMed ID: 2370893 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]